Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

September 30, 2008

Conditions
Acne Vulgaris
Interventions
DRUG

Methyl aminolevulinate (MAL) PDT

Cream application followed by illumination with red light

Trial Locations (14)

14623

Dermatology Associates of Rochester, Rochester

23507

Virginia Clinical Research, Inc., Norfolk

48038

Michigan Center for Research Corp, Clinton Twp

60563

DuPage Medical Group, Naperville

73069

Central Sooner Research, Norman

75230

Dermatology Treatment & Research, Dallas

77056

Suzanne Bruce and Associates, PA, Houston

78229

The Dermatology Clinical Research Center of San Antonio, San Antonio

84124

Dermatology Research Center, Inc., Salt Lake City

87106

Academic Dermatology Associates, Albuquerque

92123

Therapeutics Clinical Research, San Diego

94589

Solano Clinical Research, Vallejo

97210

Oregon Dermatology and Research Center, Portland

24501-1604

The Education & Research Foundation, Inc., Lynchburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Photocure

INDUSTRY

NCT00594425 - Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne | Biotech Hunter | Biotech Hunter